Sandoz Inc. is recalling 6 specific vials of Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL). This sterile injectable medication, used as a chemotherapy treatment, was exposed to temperatures outside of required limits during transportation. This deviation from Good Manufacturing Practice (GMP) standards can compromise the drug's effectiveness and safety.
The drug was exposed to improper temperatures during shipping, which could potentially reduce the potency or stability of the medication, leading to less effective treatment for patients.
Quantity affected: 6 vials. Manufactured in Austria by Fareva Unterach GmbH.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.